DNB Teknologi vs UBS Lux Equity Fund Biotech USD

DNB Teknologi vs UBS Lux Equity Fund Biotech USD

1. DNB Teknologi

  • Security

    DNB Teknologi A

  • Fee

    1.14%

  • ISIN

    NO0010337678

  • Holdings

    21

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 31 holdings in DNB Teknologi, where the largest holding is Microsoft (9.65), followed by Alphabet (7.95) and Samsung (7.93). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in DNB Teknologi and UBS Lux Equity Fund Biotech USD.

DNB Teknologi UBS Lux Equity Fund Biotech USD
1. Microsoft Corp
USA
9.65 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Alphabet Inc Class A
USA
7.95 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Samsung Electronics Co Ltd
South Korea
7.93 %
3. Moderna Inc
9.21 %
4. Nokia Oyj
5.51 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Nvidia Corp
USA
4.32 %
5. AbbVie Inc
USA
5.52 %
6. Amazon.com Inc
USA
4.28 %
6. Gilead Sciences Inc
USA
4.66 %
7. Meta Platforms A
USA
4.19 %
7. Amgen Inc
4.32 %
8. Ericsson B
Sweden
4.1 %
8. BioNTech SE
4.13 %
9. Mastercard Inc
USA
2.68 %
9. Karuna Therapeutics Inc
3.75 %
10. Capgemini SE
France
2.17 %
10. Royalty Pharma Plc
3.28 %
11. Visa Inc
USA
2.13 %
-
12. Sony Group Corp
Japan
2.03 %
-
13. Deutsche Telekom AG
Germany
1.94 %
-
14. Datadog Inc
USA
1.85 %
-
15. STMicroelectronics NV
Switzerland
1.79 %
-
16. SAP SE
Germany
1.75 %
-
17. Oracle Corp
1.58 %
-
18. Check Point Software Technologies Ltd
Israel USA
1.57 %
-
19. Take-Two Interactive Software Inc
USA
1.49 %
-
20. Adobe Inc
USA
1.33 %
-
21. Nordic Semiconductor ASA
Norway
1.29 %
-

The list of fund holdings was last updated on April 17, 2025.